Pitti Group Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-15,928
Closed -$386K 81
2025
Q2
$386K Buy
15,928
+742
+5% +$17.3K 0.33% 50
2025
Q1
$385K Buy
15,186
+1,060
+8% +$27.7K 0.39% 51
2024
Q4
$375K Buy
+14,126
New +$383K 0.38% 53

Other funds holding PFE

Pitti Group Wealth Management's PFE Position: Q3 2025 in Review

Pitti Group Wealth Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 15,928 shares — an estimated $386K sold.

Pitti Group Wealth Management first reported a position in PFE in Q4 2024 and held it in 3 quarters. The position peaked at $386K in Q2 2025. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Pitti Group Wealth Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Pitti Group Wealth Management sold 15,928 Pfizer shares in Q3 2025, an estimated $386K.
  • Pitti Group Wealth Management first reported a position in Pfizer in Q4 2024 and held it in 3 quarters.
  • Pitti Group Wealth Management's Pfizer position peaked at $386K in Q2 2025.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Pitti Group Wealth Management's 13F filing for Q3 2025, filed 7 Nov 2025.